bioMérieux
Nathalie Touboul Rotsztajn currently serves as VP Global Marketing Pharma Quality Control at bioMérieux, a position held since March 2021. Prior to this role, Nathalie worked at Boehringer Ingelheim as Global Director of Strategy and Marketing for Foot-and-Mouth Disease in Veterinary Public Health, focusing on global strategy, portfolio management, and commercial development from January 2015 to March 2021. Previous experience includes leading marketing for Foot-and-Mouth Disease at Sanofi and managing the Bluetongue and Rabies franchise at Merial. Nathalie began a career in strategic marketing at Alcimed, overseeing projects in healthcare and biotechnology. An early role as a research engineer at Fournier Pharma involved bioinformatics methods for diabetes therapeutics. Nathalie holds a Master Degree in Management of Technologies & Innovation from emlyon business school and a Master of Engineering in Biosciences from INSA Lyon.
This person is not in any teams
This person is not in any offices
bioMérieux
20 followers
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.